CS logo
small CS logo
University Hospital Gent - Department of Hematology

Gent, Belgium
University hospital in Ghent
Corneel Heymanslaan 10, 9000 Gent

About University Hospital Gent - Department of Hematology


Ghent University Hospital is one of the largest hospitals in Belgium. It is closely linked to Ghent University, the university's rector also being the hospital's president. Both the university and the hospital are autonomous entities of the Flemish Government.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University Hospital Gent - Department of Hematology


During the past decade, University Hospital Gent - Department of Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Gent - Department of Hematology" #1 collaborator was "UCB Pharma" with 1 trials as a collaborator and "Wyeth is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at University Hospital Gent - Department of Hematology


According to Clinical.Site data, the most researched conditions in "University Hospital Gent - Department of Hematology" are "B-Cell Lymphoma" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "University Hospital Gent - Department of Hematology" in a lesser frequency.

Clinical Trials Intervention Types at University Hospital Gent - Department of Hematology


Most popular intervention types in "University Hospital Gent - Department of Hematology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bosutinib" (1 trials), "Rituximab" (1 trials), "imatinib" (1 trials) and "inotuzumab ozogamicin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University Hospital Gent - Department of Hematology


The vast majority of trials in "University Hospital Gent - Department of Hematology" are 2 trials for "All" genders.

Clinical Trials Status at University Hospital Gent - Department of Hematology


Currently, there are NaN active trials in "University Hospital Gent - Department of Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University Hospital Gent - Department of Hematology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital Gent - Department of Hematology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".